Oxygen-guided red blood cell transfusion trial
This trial tests whether using a measure of oxygen in your body can guide doctors on when to give you a blood transfusion. It may help avoid unnecessary transfusions while ensuring you get enough oxygen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a hemoglobin level of 9.0 grams per deciliter or lower, confirmed by a blood test.
- You have both an arterial line and a central venous line placed, with the tip of the central line in the correct position to measure oxygen levels in your blood.
- You are 18 years or older.
- You are not pregnant.
- You do not have active bleeding, a blood cancer, sickle cell disease, or a bleeding disorder.
- You do not have moderate to severe kidney disease or acute kidney injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving blood transfusions based on each patient's needs during and after heart surgery is safe and effective. It compares different transfusion thresholds to see which works better.
This trial tests whether giving blood in a personalized way, instead of a standard approach, is better for people on a heart-lung bypass machine (VA-ECMO) for heart-related shock. It may help find a safer blood transfusion strategy while you are critically ill.
This study looks at whether giving red blood cell transfusions in a specific way is practical and safe for people receiving ECMO (a heart-lung support machine). It’s mainly a feasibility study, meaning the goal is to see if the plan can be carried out smoothly and safely.
This trial tests whether giving more or fewer red blood cell transfusions is better for adult patients on ECMO (a machine that helps your heart and lungs work). The goal is to find the best transfusion approach to improve outcomes.
This study tests a more precise way to decide when to give red blood cell transfusions to ICU patients with mild anemia. It uses a measurement called ScvO2 (a marker of how well your body is using oxygen) to see if a transfusion is needed, which may help avoid unnecessary transfusions.
This trial is testing whether a higher or lower threshold for red blood cell transfusions is better for people on ECMO (a heart-lung machine). It aims to find the safest way to manage transfusions during ECMO treatment.
Hear when a new Blood Transfusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.